Articles tagged with Viral Infections
Scientists use a novel technique to analyze virus-bacterium associations in living organisms, revealing one-to-one correspondence and potential ancient infections. The study opens new avenues for understanding coevolution between viruses and their hosts.
A new rapid test can accurately diagnose bacterial and viral infections, allowing for timely treatment. The test exploits differences in immune system responses to distinguish between the two types of infections.
Researchers have identified specific resistance mutations in the p7 protein that may explain the lack of effectiveness of current p7 inhibitor drugs. The study supports the use of combination therapies inhibiting p7 as a potential component of future HCV-specific treatments, offering new hope for effective therapies.
A meta-analysis of bacterial-virus interactions reveals a nested structure, with hard-to-infect bacteria infected by generalist viruses and easy-to-infect bacteria attacked by both generalist and specialist viruses. This discovery could improve predictions of microbial population dynamics and community assembly.
A study identified a novel sensor that is necessary to activate the immune response to viral infection. The research highlights the complex and overlapping mechanisms used by immune cells to detect viruses, providing insights into the development of more effective antiviral therapeutics.
A new study found that acute Hepatitis A virus is more efficient at evading the host's interferon response, allowing it to linger in the body for almost a year. This discovery undermines current theories on chronic Hepatitis C development and highlights the need for further research into Hepatitis-host interactions.
A new comment published in The Lancet states that numerous studies failed to replicate the findings of a 2009 XMRV detection in CFS patients. Contamination of laboratory reagents is blamed for the association between XMRV and chronic fatigue syndrome, leaving the field without a confirmed cause.
Researchers at UTHealth are exploring the link between Adenovirus-36 and obesity, with a focus on firefighters who are more likely to be overweight or obese. The study aims to design health and wellness strategies for this high-risk population.
Researchers have developed a genetically humanized mouse model for hepatitis C, enabling the testing of molecules that block the virus's entry into cells. The new model has the potential to serve as a critical role in prioritizing drug and vaccine candidates.
A combination of two adjuvants induces CD8 killer T cells to join antibodies in response to influenza infection, potentially boosting vaccine effectiveness. The strategy has promise for a universal flu vaccine that wouldn't require annual reformulation.
A new saliva test has been developed to identify cytomegalovirus (CMV) in newborns with high accuracy, enabling early detection of potential hearing loss. The test, which shows promise in a multi-center study, may revolutionize the way CMV infections are detected and treated in infants.
Researchers from NCI found XMRV unlikely to cause prostate cancer or chronic fatigue syndrome in humans. The virus arose due to genetic recombination of two mouse viruses, not present in original human tumor samples.
The introduction of direct antiviral agents (DAA) has improved virus clearance rates, particularly in patients with genotype 1, but resource scarcity raises concerns about who to treat first. A proposed plan suggests triaging therapy to the neediest patients first.
Scientists analyzed over 650 influenza viruses from Hong Kong pigs, tracing the emergence of subtypes that can infect humans. The study highlights the potential for gene-swapping between viruses and recommends continued surveillance to understand how this process might lead to new variants with human flu epidemic risks.
A long-term study reveals that increased transport of live pigs has driven an increase in the diversity of swine influenza viruses found in Hong Kong over the past three decades. The study suggests that this rising diversity may lead to a higher likelihood of swine-to-human transmission, although the risk remains unquantified.
A new experimental vaccine has shown promising results in protecting horses against the deadly Hendra virus, according to CSIRO scientists. The vaccine's successful development could help prevent the spread of the disease from flying foxes to horses and ultimately to people.
Researchers at Duke-NUS Graduate Medical School have identified a new cell type that can sense and respond to the dengue virus, which is transmitted through mosquito bites. The discovery opens up new avenues for developing vaccines and treatments for the disease, which currently lacks effective therapies.
Researchers found that Zaire ebolavirus replicates in pigs, causing disease and transmitting the virus to unexposed animals. Pigs with respiratory symptoms shed high viral loads, posing a risk of transmission to humans.
A new study at Columbia Presbyterian Medical Center reveals high rates of chronic hepatitis B infection among pregnant minority and immigrant women in NYC, with many not receiving standard care. The study highlights the importance of targeted screening and education for this vulnerable population.
Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) have developed a highly sensitive blood test for detecting human prion diseases, which are fatal brain disorders. The new method improves upon previous tests by being 10,000 times more sensitive and can rapidly detect abnormal prion proteins in blood plasma.
Research at DDW 2011 presents innovative detection practices to increase liver disease detection rates and prevent premature death. Vaccination rates against hepatitis A and B in patients with chronic liver disease are low, highlighting the need for increased vaccination efforts.
A new study found that cattle infected with foot-and-mouth disease are only contagious for 1.7 days, sparking hope for reduced culling and improved testing methods. Researchers recommend developing pre-clinical diagnostic tools to detect infected animals before symptoms appear, allowing for more targeted interventions.
Scientists have identified a single amino acid change in the chikungunya virus' exterior protein that enables it to infect Aedes albopictus mosquitoes, allowing for rapid spread across India and Southeast Asia. The discovery sheds light on why outbreaks occurred despite previous strains being present in the region.
Researchers found that current prevention and screening standards are worth the cost and may need expansion to include more of the population. Screening followed by treatment with a low-cost, high-resistance nucleoside or nucleotide is cost-effective at $29,000 per quality-adjusted life year gained.
A team of researchers identified TIM-1 as the cellular protein that acts as a receptor for Ebola and Marburg viruses. An antibody targeting TIM-1 blocks infection by both viruses, potentially providing a way to prevent initial infection and limit outbreak spread.
Researchers Peter Cummings and Michael Simpson propose that mimicking natural processes can lead to more efficient and reliable devices. By exploiting contrarian behavior and 'noise,' scientists can develop technology that outperforms traditional methods, as seen in the humble bacterial cell's ability to withstand modern medicines.
A new study analyzed mutations of the 2009 pandemic influenza A(H1N1) virus in Japan, identifying unique triple combination of bird, swine, and human flu viruses. The research revealed rapid mutation of virus strains with an extremely high evolutionary rate, paving the way for the development of new diagnostic kits.
Researchers tested an intervention targeting multiple health-related behaviors in African American couples where one partner is HIV-positive. The study found that the intervention led to increased fruit and vegetable consumption, physical activity, and cancer screenings among participants.
Researchers found that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death in mice infected with lethal doses of influenza virus. The study suggests a novel method to confer marked resistance to influenza by enhancing innate immune mechanisms.
A new study on deer mice on California's Channel Islands has found that precipitation, predator diversity, and island characteristics are key factors in regulating the spread of hantavirus. The research suggests that a stronger relationship between climate change and human health risk may exist than previously thought.
Researchers have identified two bioflavonoids, catechin and naringenin, with antiviral activity against hepatitis C virus. These compounds, combined with existing flavonoid quercetin, may provide a promising therapy for millions of people worldwide.
Researchers have found that flu virus infection is necessary for pneumococcal bacteria to efficiently spread between individuals. The study has implications for managing influenza pandemics and reducing pneumococcal infections in young children, who are highly susceptible.
Cytotoxic T cells (CTLs) get a head start on viral replication by dividing early during their journey to infected tissue. This allows them to quickly respond to the virus upon arrival, making them more effective in defending against infection.
A Phase II dose-ranging study of BMS-790052 plus PEG-interferon alfa and ribavirin showed higher rates of sustained virologic response compared to PEG-interferon alfa and ribavirin alone. The regimen achieved up to 92% SVR12 in treatment-naïve patients with hepatitis C genotype 1.
Researchers have successfully infected and replicated swine hepatitis E virus in human hepatocytes, confirming its zoonotic potential. This breakthrough verifies the infectious disease can be transmitted from animals to humans., Hepatitis E is a major cause of epidemic and acute sporadic hepatitis worldwide.
Clinical trials confirm efficacy and safety of new protease inhibitors in combination with PegIFN-alpha and ribavirin for HCV patients who have previously failed therapy. The treatments demonstrated good response rates at key timepoints and remarkably high sustained viral response rates.
A two-year trial found that switching from entecavir to lamivudine resulted in a 24% virologic rebound rate and 12% drug-resistance rate. Patients who continued on entecavir therapy maintained undetectable HBV DNA levels.
New data reveals novel lymphocyte-hepatocyte interactions regulated by HCV, affecting CD4+ T-cell trafficking and cytokine expression. This understanding may influence anti-viral immune responses and chronic HCV replication.
Researchers at Dana-Farber Cancer Institute have identified a promising target for an AIDS vaccine: the V3 loop of the virus's protein envelope. Immune system antibodies aimed at this loop may offer protection against multiple genetic subtypes of HIV-1, offering hope for a universally effective vaccine.
A new three-drug cocktail has been shown to eliminate the hepatitis C virus in patients more effectively than the current two-drug regimen, with significantly higher rates of sustained virologic response. This breakthrough treatment offers new hope for patients who have not responded to previous therapy.
A new study finds that a human respiratory virus has killed two mountain gorillas in Rwanda, confirming the risk of disease transmission between humans and animals. The virus, human metapneumovirus (HMPV), was detected in both gorillas, highlighting the need for increased conservation efforts to protect these endangered animals.
A new Johns Hopkins study shows that each strain of the cat-borne parasite Toxoplasma gondii triggers a unique reaction in human nerve cells, varying the severity of infection. The research found alterations triggered by the most virulent strain to be linked to brain development and central nervous system function.
Researchers identify resistance to cucurbit yellow stunting disorder virus (CYSDV) in exotic melon varieties, with potential applications for the southwestern United States. Whitefly populations and high temperatures exacerbate CYSDV infection, highlighting the need for integrated management strategies.
A cohort study found that hepatitis B virus (HBV) infection decreases the percentage of metastases in colorectal cancer patients, while increasing extrahepatic metastases. This suggests HBV may serve as a prognostic factor for hepatic metastasis formation in CRC patients.
Researchers at the University of Edinburgh have discovered a direct link between cholesterol levels and the immune system's response to viral infections. By lowering cholesterol, the body can starve viruses of the nutrients they need to grow, potentially enhancing the immune system's ability to fight off infections.
Researchers discovered a critical link between respiratory syncytial virus and oxidative stress, which causes lung inflammation and damage in children. The study found that the virus blocks the activity of Nrf2, a protein needed for antioxidant enzymes, leading to increased reactive oxygen species and cell killing.
Researchers have identified a small virus that targets and rescues infected zooplankton from death. The discovery sheds light on the evolutionary origin of jumping genes found in other organisms.
Researchers discovered that DMXAA enhances flu vaccine efficacy by causing the body to produce its own antiviral proteins. The drug may also treat newly emerging flu strains and possibly other viruses, offering a potential lifesaving therapy for millions.
Researchers found no evidence of viral infection causing acute exacerbation of idiopathic pulmonary fibrosis (IPF) in most patients. Instead, torque teno virus (TTV) was detected in lung fluid samples from a small percentage of IPF patients, suggesting it may be a marker of lung injury rather than a cause.
A recent study found that hepatitis C patients in the US are twice as likely to be uninsured, with only a third having access to antiviral therapy. The lack of adequate health insurance coverage is a significant barrier to treatment, particularly for those with comorbidities.
A cancer-causing retrovirus exploits key proteins in host cells to extend cell life and spread. The study found that the viral protein targets ATM and REG-gamma, leading to prolonged cell survival and increased virus transmission.
New research shows reovirus-infected cancer cells release pro-inflammatory proteins that recruit and activate white blood cells, killing cancer. A cellular signalling protein, Ras, is abnormally activated in many cancers, providing a window of opportunity for reovirus infection.
The Dengue Vaccine Initiative aims to accelerate the development and utilization of safe, affordable, and broadly protective vaccines to combat dengue fever. The initiative will generate data on the burden of disease, potential private demand, cost of illness, and seroprevalence in several countries.
Researchers found that a viral infection in a parasite can trigger severe responses in immune cells, increasing disease severity. The study suggests that antiviral strategies could be used to reduce damage caused by Leishmania strains carrying viruses.
The economic burden of dengue fever in the Western Hemisphere surpasses other viral illnesses, with estimated annual costs of $2.1 billion. Direct and indirect costs include ambulatory care, hospitalization, productivity losses, and government expenditures.
Researchers at the University of Southampton successfully crystallized a key norovirus enzyme, paving the way for the development of an antiviral treatment. The breakthrough could help alleviate the significant public health burden caused by noroviruses, which are responsible for one million cases in the UK each year.
A study by Virginia Tech researchers found that airborne influenza A viruses can remain suspended in the air for hours and are associated with fine particles less than 2.5 micrometers. The average concentration of viruses was 16,000 per cubic meter of air, which is sufficient to induce infection.
The European Diabetes Research Network, funded by the EU, will investigate the possible role of virus infection in causing type 1 diabetes. The network aims to develop a vaccine to prevent diabetes in children and improve diagnosis and patient care.
A study published in the World Journal of Gastroenterology investigated the seroprevalence of Hepatitis A virus (HAV) antibodies among patients with chronic viral liver disease in South Korea. The study found that most patients above 40 years old have already been exposed to HAV, highlighting the need for vaccination against HAV.
Researchers discover naturally occurring viral infections in C. elegans, a millimeter-long worm used extensively for decades to study many aspects of biology. The findings provide insights into the way viruses and their hosts interact, shedding light on fundamental phenomena such as RNA interference and cell self-destruction.